📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Shark variable new antigen receptor biologics - a novel technology platform for therapeutic drug development. (2014)

First Author: Kovaleva M

Attributed to: To benchmark the utility of E06: A half-life extension, single-domain, shark antibody bio-tool, and progress it to a Phase 1 ready candidate clone funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1517/14712598.2014.937701

PubMed Identifier: 25090369

Publication URI: http://europepmc.org/abstract/MED/25090369

Type: Journal Article/Review

Volume: 14

Parent Publication: Expert opinion on biological therapy

Issue: 10

ISSN: 1471-2598